In the HER2-negative cohort, one patient experienced a durable CR (23 weeks) and had a primary tumour with the following molecular characteristics: HER2 negative and EGFR negative; ER positive and PgR positive; low expression of PTEN and PIK3CA (E767K) SNP. This evidence concerns the gene PIK3CA and neoplasm.